Results

Total Results: 1,653 records

Showing results for "described".

81. Disposition of Comments Report for Acute Migraine Treatment in Emergency Settings (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-emergency_disposition-comments.pdf
    November 27, 2012 - Peer Reviewer #4 Methods A comprehensive search strategy described well enough for replication. … The statistical methods are clearly described and appropriate. … Peer Reviewer #3 Results The studies are well described. … Peer Reviewer #9 Results Not clearly described. … Limitations are well described and implications well stated. Thank you for your comment.

82. Disposition of Comments Report for Decision Aids for Cancer Screening and Treatment (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-decision-support-tools_disposition-comments.pdf
    December 23, 2014 - TEP Reviewer #1 Introduction The authors described the impetus for this study well. … Peer Reviewer #2 Methods Methods are all well justified, logical, appropriate and well described. … This is clearly described in the Methods Section. … Peer Reviewer #3 Results The characteristics of the studies are clearly described? … The limitations are described adequately. No action required.

83. Chronic-Cough Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-cough_executive.pdf
    March 01, 2014 - We accepted as chronic any cough described as such, or that exceeded 8 weeks in adults and adolescents … In addition, we described comparators carefully, as treatment standards may have changed during the … Applicability We assessed applicability across our KQs using the method described in the Methods Guide … The 48 studies were described in 42 publications. … However, our decision to include studies that described their population as suffering with chronic

84. Disposition of Comments for Treatments for Seasonal Allergic Rhinitis (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/allergy-seasonal_disposition-comments.pdf
    July 17, 2013 - Two different comparisons are described: In comparison to combination oral selective antihistamine plus … The methodology is described in detail and the report demonstrates a truly major effort to explore many … After revising our method of data synthesis (as described in the revised Methods section), SMD was no … TEP #3 Results The studies are adequately described & the tables are user friendly. … The characteristics of the studies reviewed are adequately described and also referenced so that if

85. Disposition of Comments Report for Pharmacologic and Mechanical Prophylaxis of Venous Thromboembolism Among Special Populations (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_disposition-comments.pdf
    May 29, 2013 - Filter thrombosis was not described as an outcome for any of the other KQs. … We have described the risk of bias among included studies as an appendix. … use of IVCF; this is described. … The yield is described in the results (scant). … Reviewer 10 Discussion "Are the limitations of the review/studies described adequately?"

86. Disposition of Comments Report for Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_disposition-comments.pdf
    June 07, 2013 - TEP Member 4 Executive Summary Data extraction and synthesis are well described and appropriate. … TEP Member 4 Executive Summary KQ2 and 3 are well described Thank you. … Introduction/ Methods/ Literature Search Results The methods are well-described. … OCs and Ovarian Cancer This section had the appropriate amount of detail, clearly described study … TEP Member 4 General The report is clinically meaningful and well described. Thank you.

87. A Framework for Conceptualizing Evidence Needs of Health Systems (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/white-paper-framework-for-conceptualizing-evidence-needs_0.pdf
    December 01, 2017 - Health Services Offerings Several studies described use of evidence in strategic decisionmaking and … Studies by Makkar 201513, Aicken 201251, Goetghebeur 200852, Munn 201453, and Munn 201453 described … This trustworthiness was described in two ways: • How trustworthy is the evidence? … They described a conceptual model in which knowledge is available in a machine executable form, and … Mitchell 2010, writing about the Penn Medicine CEP has described their experience gathering external

88. Disposition of Comments for CER 158 Diagnosis of Gout (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout-diagnosis-disposition-160727.pdf
    February 24, 2016 - TEP 5 General Comments Almost all of what I described in the aforementioned paragraph is touched … When we described the findings of the Ogdie review, both in the sections on US and on DECT. … The challenge is that the construct of the disease is often described with MSU crystals as the gold … Either these studies need to be added and described along with their strengths and limitations, or … Peer Reviewer 5 Results Study characteristics have been adequately described. Thank you.

89. Disposition of Comments for Management of Suspected Opioid Overdose With Naloxone by Emergency Medical Services Personnel (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-193-disposition-comments-naloxone.pdf
    November 27, 2017 - As described in the Methods, we included the FDA-approved nasal formulation. … As described in the Results, data on harms was very limited. … The current armamentarium of naloxone formulations are adequately described, as well. … The inclusion criteria are described in detail in the methods using the PICOTS approach. … The characteristics of the studies are clearly described.

90. Disposition of comments for CER 169 Low Back Pain (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/back-pain-treatment_disposition-comments.pdf
    February 29, 2016 - As described in the Methods, we focused on between-group differences in outcome measures. … As described in the Methods, we did not include non-RCTs for evaluating effectiveness. … As described in the Methods, we did not include non-RCTs for evaluating effectiveness. … As described in the methods, cohort studies of harms were included. … The limitations of the review and included studies are described adequately.

91. Disposition of Comments: Comparative Effectiveness Review No. 273_Treatment of Stages I-III Squamous Cell Anal Cancer: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-273-anal-cancer-disposition-comments.pdf
    August 20, 2024 - • Overall, reviewers described the review report as “excellent”, “very well written”, and “most … in the report, it was mentioned that “this does not mean that none of the individual interventions described

92. Dietary Intake of Polyunsaturated Fatty Acids and Plasma Lipid and Cardiovascular Events (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/polyunsaturated-fatty-protocol.pdf
    January 01, 2024 - Methods The systematic review will follow the EPC Program methodology, as described in its Methods … Studies will be included in the review based on the study-specific inclusion and exclusion criteria described … Combination of long-chain PUFA (e.g., EPA+DHA+DPA; DHA+ALA) ● PUFA intake must be defined or described … comparative studies  Must account for potential confounders  Dietary intake must be defined or described … Data Synthesis Each study will be described in summary and evidence tables presenting study design

93. Dietary Total Fat Intake and Dietary Polyunsaturated Fatty Acid Intake and Child Growth and Development Outcomes: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/child-growth-development-outcomes-protocol-amended.pdf
    November 18, 2024 - We will triage abstracts using a modified review approach, described in the Study Selection section … Study Selection We will use pre-defined criteria described in Table 1 to screen citations (titles and … Studies will be rated as being “low,” “moderate,” or “high” risk of bias as described below in Table … Studies will be described using a hierarchy-of-evidence approach, where the best evidence will be the … The strength of the evidence may be downgraded based on the limitations described above.

94. Comparative Effectiveness Review No. 266_Cervical Degenerative Disease Treatment: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-266-cdd-executive-summary.pdf
    November 01, 2023 - Methods This review follows standard methods for systematic reviews5 that are further described in … with artificial disc replacement than ACDF; however, indication for reoperation was not consistently described

95. Digestible Carbohydrate Intake and Maternal-Infant Outcomes: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/carbohydrate-intake-protocol.pdf
    April 08, 2024 - Study Selection: In accordance with the AHRQ Methods Guide,46 we will use the pre-defined criteria described … Studies will be rated as being “low,” “moderate,” or “high” risk of bias as described below in Table … Studies will be described using a hierarchy-of-evidence approach, where the best evidence will be the … outcome will be initially assessed by one researcher for prioritized outcomes by using the approach described … noted as “no evidence” The strength of the evidence may be downgraded based on the limitations described

96. Respectful Maternity Care: Dissemination and Implementation of Perinatal Safety Culture to Improve Equitable Maternal Healthcare Delivery and Outcomes (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/respectful-maternity-care-protocol.pdf
    September 16, 2022 - ’ may be defined by geography, race/ethnicity, age, disability, language, education, SES, etc., as described … Contextual Question: This question aims to identify definitions and components of RMC described in the … for Effectiveness and Comparative Effectiveness Reviews,47 we will use the pre-established criteria described … Effectiveness Reviews.47 Studies will be rated as being “low,” “moderate,” or “high” risk of bias as described … noted as “no evidence” The strength of the evidence may be downgraded based on the limitations described

97. Development of a Primary Care Guie for Implementing Evidence-Based Screening and Counseling for Unhealthy Alcohol Use With Epic-Based Electronic Health Record Tools: A Pilot Dissemination Project (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-research-report-unhealthy-alcohol-use-final.pdf
    September 01, 2018 - Three of the original team members, described below, served as health system representatives in the … In addition to the health system representatives on the original team, described above, other original … In sections of the package corresponding to the most important components, we described our implementation … patterns who are screened for the first time are often in the pre-contemplative stage of change, as described … Our questions, based on dimensions described in the RE-AIM (Reach, Efficacy, Adoption, Implementation

98. Methods Guide for Medical Test Reviews Chapter 11 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-genetic_methods.pdf
    July 01, 2012 - for Comparative Effectiveness Reviews.2 We do not attempt to reiterate the challenges and principles described … the result of a single mutated gene and may be passed on to subsequent generations in various well described … Some of the terms described below (penetrance, variable expressivity, and pleiotropy) are generally … deemed significant). 11-4 Principles for Addressing the Challenges The eight principles described … What safeguards have been described and are these safeguards in place and effective?

99. Methods Guide for Medical Test Reviews Chapter 6 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-applicability_methods.pdf
    July 01, 2012 - If the patient population and care setting are not explicitly described, the default decision can be … In applying the principles described below, the PICOTS typology can serve as a framework for assuring … Source of population not described. Study population poorly specified. … Training/quality control not described. Screening and diagnostic uses mixed. … Ultrasound machines and training of sonographers not described in study of fetal nuchal translucency

100. Methods Guide for Medical Test Reviews Chapter 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-topics_methods.pdf
     July 01, 2012 - While this chapter is intended to serve as a guide for EPCs, the processes described here are relevant … The AHRQ EPC program has described the development and use of analytic frameworks in systematic reviews … Harris and colleagues have described the value of the analytic framework in assessing screening tests … Various other frameworks (generally termed “organizing frameworks,” as described briefly in the Introduction … In addition to the examples described here, the AHRQ Effective Health Care Program Web site (http://